Investigating IL-31 as a Novel Candidate Pathway for Prurigo Nodularis (PN)

Time: 12:05 pm
day: Day One

Details:

  • Exploring the scientific rationale for investigating IL-31 in PN
  • Unravelling key findings in phase 2 clinical data
  • Elucidating the mechanism of action of nemolizumab in PN using a multi-omics approach

Speakers: